Clinical trial
The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using…
NCT00111228 · Medtronic Diabetes, Industry · Completed
Key facts
| NCT number | NCT00111228 |
|---|---|
| Title | The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT |
| Official title | Randomised, Controlled, Multi-centric, Clinical Study to Assess Whether Type 1 Diabetic Patients in Poor Glycemic Control Can Improve Using the Real-time Values of Guardian T Versus Conventional Self-Monitoring Blood Glucose |
| Lead sponsor | Medtronic Diabetes, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Device |
| Interventions | Guardian RT, SMBG only |
| Enrollment | 162 |
| Start date | Oct 1, 2004 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | May 19, 2005 |
| Last update posted | Apr 1, 2019 |
| Countries | France, Germany, Israel, Italy, Slovenia, Sweden, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: